펄스 바이오 (PLSE)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

펄스 바이오 Stock (PLSE) Company Profile

Pulse Biosciences Inc

Healthcare (1115)

510-906-4600

3957 POINT EDEN WAY, HAYWARD, CA

@PulseBioNPS

최신 SEC 제출 서류

PLSE's Discussions on Twitter

PLSE을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
PLSE Pulse Biosciences Inc	14.25	955.52M	-9,000	-68.03M	-44.76M	-1.05
ISRG Intuitive Surgical Inc	535.00	191.90B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	207.11	59.36B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	79.00	39.13B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	257.58	38.05B	5.26B	1.44B	1.76B	9.7713
MDLN Medline Inc	44.12	33.62B	27.43B	1.27B	1.01B	1.5829

펄스 바이오 Stock (PLSE) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-07-07	개시	Oppenheimer	Outperform
2021-07-27	개시	Stephens	Overweight
2021-03-11	개시	Maxim Group	Buy
2021-01-26	재확인	H.C. Wainwright	Buy
2020-05-12	업그레이드	H.C. Wainwright	Neutral → Buy
2020-02-14	다운그레이드	H.C. Wainwright	Buy → Neutral
2019-02-25	개시	H.C. Wainwright	Buy

펄스 바이오 주식(PLSE)의 최신 뉴스

펄스 바이오 (PLSE) 재무 분석

펄스 바이오 주식 (PLSE) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Danahy Kevin Patrick	Chief Commercial Officer	Oct 02 '25	Sale	18.53	4,600	85,238	43,298
Danahy Kevin Patrick	Chief Commercial Officer	Sep 18 '25	Option Exercise	1.53	20,000	30,600	63,298
Danahy Kevin Patrick	Chief Commercial Officer	Sep 19 '25	Option Exercise	1.53	400	612	43,698
Danahy Kevin Patrick	Chief Commercial Officer	Sep 18 '25	Sale	18.49	20,000	369,800	43,298
Danahy Kevin Patrick	Chief Commercial Officer	Sep 19 '25	Sale	18.48	400	7,392	43,298
UECKER DARRIN	Chief Technology Officer	Sep 17 '25	Option Exercise	4.00	181,534	726,136	284,406
UECKER DARRIN	Chief Technology Officer	Sep 16 '25	Option Exercise	4.00	25,000	100,000	147,872
UECKER DARRIN	Chief Technology Officer	Sep 16 '25	Sale	16.28	25,000	407,000	122,872
UECKER DARRIN	Chief Technology Officer	Sep 17 '25	Sale	16.21	20,000	324,200	122,872

펄스 바이오 (PLSE)

펄스 바이오 Stock (PLSE) Company Profile

PLSE을(를) 다른 주식과 비교

펄스 바이오 Stock (PLSE) Upgrades & Downgrades

펄스 바이오 주식(PLSE)의 최신 뉴스

Trading the Move, Not the Narrative: (PLSE) Edition - Stock Traders Daily

Dividend Watch: Is Pulse Biosciences Inc stock influenced by commodity pricesJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 1.4%Here's What Happened - MarketBeat

Pulse Biosciences Nabs FDA IDE Approval for nPulse Cardiac Catheter Ablation System Study - Medical Product Outsourcing

Pulse Biosciences updates investor deck on cardiac pipeline - TipRanks

Pulse Biosciences, Inc. Updates Investor Presentation - TradingView — Track All Markets

Earnings Miss: Is Pulse Biosciences Inc. exposed to currency risksWeekly Stock Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Analyst Calls: Is Pulse Biosciences Inc stock recession proof2025 Earnings Impact & Daily Profit Focused Screening - Bộ Nội Vụ

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 51% Potential Upside - DirectorsTalk Interviews

New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences (PLSE) - simplywall.st

How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance

How buybacks impact Pulse Biosciences Inc. stock valueEarnings Recap Summary & Free Verified High Yield Trade Plans - Улправда

Will Pulse Biosciences Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Verified Trade Idea Suggestions - Улправда

Will Pulse Biosciences Inc. (6L8) stock profit from automation wave2025 Key Highlights & Entry Point Confirmation Signals - ulpravda.ru

Pulse Biosciences appoints healthcare veteran Maria Sainz to board By Investing.com - Investing.com Nigeria

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - 01net

Pulse Biosciences Adds Veteran Healthtech Leader to Board - TipRanks

Pulse Biosciences Elects Maria Sainz to Board of Directors - TradingView — Track All Markets

Pulse Biosciences appoints healthcare veteran Maria Sainz to board - Investing.com

Can Pulse Biosciences Inc. stock continue upward trendPortfolio Performance Summary & Growth Focused Entry Reports - ulpravda.ru

Weekly Earnings: Will Pulse Biosciences Inc. (6L8) stock outperform value peersEarnings Overview Summary & Growth Focused Entry Reports - Улправда

Will Pulse Biosciences Inc. stock reach Wall Street targetsMarket Trend Review & Real-Time Volume Trigger Notifications - Улправда

Is MBX Biosciences Inc. stock positioned well for digital economyJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда

Why Pulse Biosciences Inc. stock remains resilient2025 Key Lessons & Daily Stock Momentum Reports - Улправда

Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsMarket Weekly Review & Safe Capital Allocation Plans - Улправда

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium - Bluefield Daily Telegraph

(PLSE) Volatility Zones as Tactical Triggers - Stock Traders Daily

Working capital per share of Pulse Biosciences, Inc. – DUS:6L8 - TradingView — Track All Markets

What analysts say about Pulse Biosciences Inc 6L8 stockEarnings Growth Projections & Test Our Stock Screener — Free Forever - Early Times

Value Recap: Is The E.W. Scripps Company stock a buy in volatile marketsLong Setup & Daily Market Momentum Tracking - moha.gov.vn

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Bluefield Daily Telegraph

Total debt per share of Pulse Biosciences, Inc. – MUN:6L8 - TradingView — Track All Markets

Positron (OTCMKTS:POSC) vs. Pulse Biosciences (NASDAQ:PLSE) Critical Comparison - Defense World

What drives Pulse Biosciences Inc 6L8 stock priceHigh Dividend Yield Stocks & High Profit Market Growth - earlytimes.in

MSN Money - MSN

Understanding the Setup: (PLSE) and Scalable Risk - Stock Traders Daily

Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial - Sahm

Pulse Biosciences Updates Investors on Product Advancements - MSN

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring A 44.74% Potential Upside - DirectorsTalk Interviews

Why Pulse Biosciences (PLSE) Is Up 8.0% After FDA Clears Pivotal Atrial Fibrillation Trial - Sahm

Pulse Biosciences holds 2025 annual stockholder meeting - MSN

Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Sahm

Can Pulse Biosciences Inc. stock beat market expectations this quarterEarnings Recap Report & Growth Focused Stock Reports - Улправда

What technical signals suggest for Pulse Biosciences Inc. stockSell Signal & AI Driven Price Forecasts - Улправда

Pulse Biosciences announces inducement grants under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Market Pulse: How Aura Biosciences Inc. stock performs in high volatility marketsWall Street Watch & Long-Term Safe Investment Ideas - Улправда

Aug Fed Impact: Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - Улправда

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial - sharewise.com

How Pulse Biosciences Inc. stock responds to policy changesMarket Risk Summary & Daily Risk Controlled Trade Plans - DonanımHaber

Can Pulse Biosciences Inc. stock resist market sell offs2025 Support & Resistance & Community Verified Trade Signals - DonanımHaber

펄스 바이오 (PLSE) 재무 분석

매출

순이익

현금흐름

주당 순 이익

펄스 바이오 주식 (PLSE) 내부자 거래

PLSE과 유사한 종목